At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted Aug 10, 2001·Updated Mar 16, 2016
In Brief
An observational study for Asthma and Lung Diseases. Completed.
Detailed Summary
To examine the cellular and molecular mechanisms of corticosteroid and leukotriene receptor antagonists, focusing on their effects on T lymphocytes during both chronic (18 months) and acute therapy.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma, Lung Diseases
Countries--
CollaboratorsAsthma Clinical Research Network
Timeline
N/ACompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2001
First PostedAug 2001
Study CompletionMar 2005
TodayJul 2026
First PostedAug 10, 2001
Enrollment StartApr 1, 2001
Study CompletionMar 1, 2005
TodayJul 2, 2026
Posted 24.9 years ago